|
Volumn 32 Suppl 2, Issue , 2009, Pages
|
Early insulin use in type 2 diabetes: what are the cons?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
GLYCOSYLATED HEMOGLOBIN;
INSULIN;
SULFONYLUREA DERIVATIVE;
BLOOD;
CHEMICALLY INDUCED DISORDER;
COLORECTAL TUMOR;
DIABETIC ANGIOPATHY;
DRUG EFFECT;
HUMAN;
HYPOGLYCEMIA;
METABOLISM;
MICROCIRCULATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
RISK;
TREATMENT OUTCOME;
COLORECTAL NEOPLASMS;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
INSULIN;
MICROCIRCULATION;
RISK;
SULFONYLUREA COMPOUNDS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 75549083156
PISSN: None
EISSN: 19355548
Source Type: Journal
DOI: 10.2337/dc09-s321 Document Type: Note |
Times cited : (21)
|
References (29)
|